The AstraZeneca Covid-19 vaccine will continue to be administered in this country but with caution among women under the age of 60 as very rare cases of blood clots have been reported to have occurred among this group.

This decision was reached by the health authorities after the European Medicines Agency declared there could be a "possible link" between AstraZeneca's vaccine and "very rare cases of abnormal blood clots" in people who have been vaccinated. People wishing to get this vaccine will be questioned whether they take contraceptives, whether they smoke or have high blood pressure, female patients who are overweight will be carefully monitored as well.

“After 230,000 doses of the vaccine were administered in this country not a single case of thrombocytopenia or bleeding has been reported,” said Bogdan Kirilov, director of the Bulgarian Drug Agency.

At the videoconference of the EU health ministers held last night, Bulgaria’s Minister of Health Prof. Kostadin Angelov insisted on a uniform EU-wide decision regarding the AstraZeneca vaccine.